Furthermore, tumor markers such as AFP, CEA, and CA199 often have limited clinical value in PHL diagnosis, as they are frequently negative, except in cases of HCC with slightly elevated AFP levels (9, 21, 22). This evidence concerns the gene CEACAM5 and hepatocellular carcinoma.